Research on clinical application of Fufang Kushen Injection in treating indication (therioma) in real world based on hospital information system database / 中草药

ABSTRACT

To analyze the clinical application of Fufang Kushen Injection in treating indication (therioma) in the real world based on hospital information system (HIS) database, and provide references for clinical application of Fufang Kushen Injection. A total of 44 588 patients with therioma were extracted from the electronic medical data using Fufang Kushen Injection from 22 large-scale 3A hospitals based on HIS. We have made a descriptive analysis based on frequency and rate of general information, western medicine diagnosis, dosage, course of treatment, combination medication, and discharge outcomes. The average age of patients treated with Fufang Kushen Injection for therioma was 57.30 years old; The male patients were more than females; Oncology and outpatient admissions were the main criteria, and most of the admissions were general; The frequency distribution of western medicine diagnosis with Fufang Kushen Injection were lung, liver, stomach, colon, breast, and other malignant tumors; The maximum dosage was 10-20 mL; The common course of treatment was 4-7 d; The combination of clinical common drugs include antineoplastic chemotherapeutic agents, immunomodulatory drugs, antibiotics, glucocorticoid drugs, 5-HT receptor blockers, etc. Fufang Kushen Injection has been widely used in the clinical treatment of therioma with different systems and different conditions. The characteristics of the indication population are clear, and it conforms to the general rule of therioma; The clinical dosage and course of treatment basically meet the requirements of the variety specification, and the type of combination drugs is more extensive.